EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Computing lifetime incidence of esophageal adenocarcinoma and age-specific prevalence of Barrett’s esophagus

Ravi Vissapragada, Norma B Bulamu, David C Whiteman, Tim Bright, Jonathan Karnon, David I Watson

Diseases of the Esophagus · 03.05.2025 · 38 (3)

DOI: 10.1093/dote/doaf038 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Diseases of the Esophagus, online erschienen am 17.05.2025. Verfasst von Ravi Vissapragada und 5 weiteren Autor:innen. Beteiligte Einrichtung: Discipline of Surgery, College of Medicine and Public Health, Flinders University, Adelaide, Australia. Hauptthemen laut MEDLINE: Barrett Esophagus, Esophageal Neoplasms, Adenocarcinoma. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Barrett’s esophagus is the precursor to esophageal adenocarcinoma. Esophageal adenocarcinoma detected from endoscopic surveillance programs accounts for <10% of all cases, suggesting majority of patients with Barrett’s esophagus are likely unaccounted for. Previous observational studies have estimated the observed prevalence of Barrett’s esophagus to be approximately 1%, but others suggest may be an underestimate. The aim of this study was twofold: (i) calculate lifetime risk of esophageal adenocarcinoma and (ii) estimate overall and age-specific prevalence of Barrett’s esophagus. A tree cohort model was created for progression to esophageal adenocarcinoma from birth to death (100 years) for USA and Australian population. Lifetime risk of esophageal cancer and adenocarcinoma were necessary for calculating Barrett’s esophagus prevalence. The model incorporated age- and sex-specific incidence data from national cancer registries: the Australian Institute of Health and Welfare and the Surveillance, Epidemiology, and End Results database for the USA. The model was calibrated using an optimization algorithm, which matched progression rates from Barrett’s esophagus to esophageal adenocarcinoma with known national cancer data. A Monte Carlo simulation, with 10,000 iterations, was conducted to derive error margins. Estimates of age-specific and overall prevalence of Barrett’s esophagus in the population were generated through a similar process. Results: The lifetime risk of esophageal cancer and adenocarcinoma in USA non-Hispanic White population was 0.56% and 0.36%, respectively, while it was somewhat higher at 0.81% and 0.61% (range 0.57%–0.65%) in the Australian population. Estimated overall prevalence of Barrett’s esophagus was ~3% (±0.3%) and ~ 5.4% (±0.6%) in USA White and Australian populations (male and female). Prevalence for age brackets was estimated at 0.06% (±0.02%), 1.6% (±0.7%), 3.2% (±1.3%), 8% (±3%), and 12% (±4%) for USA, and 0.05% (±0.02%), 0.9% (±0.5%), 2.8% (±1.2%), 7% (±3%), and 12% (±4%) for Australian population for ages 0–29, 30–44, 45–59, 60–74, and 75+, respectively. Observed estimates of Barrett’s esophagus prevalence are likely lower than projected overall prevalence. This study also presents age-specific prevalence estimates of Barrett’s esophagus, which are key in developing screening programs for esophageal adenocarcinoma.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Barrett EsophagusEsophageal NeoplasmsAdenocarcinomaHumansAustraliaMaleFemaleIncidencePrevalenceUnited StatesMiddle AgedAgedAdultAged, 80 and overMonte Carlo MethodDisease ProgressionAdolescentSEER ProgramInfantAge DistributionChildAge FactorsYoung Adult

Stichwörter der Autor:innen

Barrett’s esophagusesophageal adenocarcinomalifetime riskprevalence

Autor:innen und Institutionen

  • Discipline of Surgery, College of Medicine and Public Health, Flinders University, Adelaide, Australia.
  • Flinders Health and Medical Research Institute, College of Medicine and Public Health, Flinders University, Adelaide, Australia.
  • Population Health Department, QIMR Berghofer Medical Research Institute, Brisbane, Australia.
  • Faculty of Medicine, The University of Queensland, Herston, QLD, Australia.
  • Department of Surgery, Flinders Medical Centre, Adelaide, Australia.

Zitieren

APA

Vissapragada, R., Bulamu, N. B., Whiteman, D. C., Bright, T., Karnon, J., & Watson, D. I. (2025). Computing lifetime incidence of esophageal adenocarcinoma and age-specific prevalence of Barrett’s esophagus. Diseases of the Esophagus, 38(3). https://doi.org/10.1093/dote/doaf038

Vancouver

Vissapragada R, Bulamu NB, Whiteman DC, Bright T, Karnon J, Watson DI. Computing lifetime incidence of esophageal adenocarcinoma and age-specific prevalence of Barrett’s esophagus. Diseases of the Esophagus. 2025;38(3). doi:10.1093/dote/doaf038

BibTeX
@article{Vissapragada2025,
  author = {Vissapragada, Ravi and Bulamu, Norma B and Whiteman, David C and Bright, Tim and Karnon, Jonathan and Watson, David I},
  title = {Computing lifetime incidence of esophageal adenocarcinoma and age-specific prevalence of Barrett’s esophagus},
  journal = {Diseases of the Esophagus},
  year = {2025},
  volume = {38},
  number = {3},
  doi = {10.1093/dote/doaf038}
}
Kostenlos starten →